148 related articles for article (PubMed ID: 36974689)
1. Indications for surgical resection of complicated infantile hemangiomas in the β-blocker's era: a single-institution experience from a retrospective cohort study.
Beqo BP; Gasparella P; Flucher C; Spendel S; Quehenberger F; Haxhija EQ
Int J Surg; 2023 Apr; 109(4):829-840. PubMed ID: 36974689
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
3. A commentary on 'Indications for surgical resection of complicated infantile hemangiomas in the β-blocker's era: a single-institution experience from a retrospective cohort study'.
Chen T; Ye B; Xu Y; Pang F
Int J Surg; 2023 Dec; 109(12):4389-4390. PubMed ID: 37713510
[No Abstract] [Full Text] [Related]
4. Surgical resection of infantile hemangiomas following medical treatment with propranolol versus corticosteroids.
Polites SF; Watanabe M; Crafton T; Jenkins TM; Alvarez-Allende CR; Hammill AM; Dasgupta R
J Pediatr Surg; 2019 Apr; 54(4):740-743. PubMed ID: 30249358
[TBL] [Abstract][Full Text] [Related]
5. Predictors of poor response to oral propranolol in infantile hemangiomas.
Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S
Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367
[TBL] [Abstract][Full Text] [Related]
6. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
7. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
[TBL] [Abstract][Full Text] [Related]
8. Propranolol and infantile hemangiomas: Outcome from a tricentric study.
Benetton C; Pace MD; De Corti F; Cimador M; Gamba P; Midrio P
J Plast Reconstr Aesthet Surg; 2023 Jan; 76():57-59. PubMed ID: 36513008
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment outcomes of infantile hemangioma in children: Does prior medical treatment matter.
Tangtatco JA; Freedman C; Phillips J; Pope E
Pediatr Dermatol; 2018 Nov; 35(6):e418-e419. PubMed ID: 30187523
[TBL] [Abstract][Full Text] [Related]
10. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
11. Propranolol and infantile hemangiomas four years later: a systematic review.
Marqueling AL; Oza V; Frieden IJ; Puttgen KB
Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
[TBL] [Abstract][Full Text] [Related]
12. Surgical Intervention of Periocular Infantile Hemangiomas in the Era of β-Blockers.
Men CJ; Ediriwickrema LS; Paik JS; Murdock J; Yen MT; Ng JD; Liu CY; Korn BS; Kikkawa DO
Ophthalmic Plast Reconstr Surg; 2020; 36(1):70-73. PubMed ID: 31809485
[TBL] [Abstract][Full Text] [Related]
13. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
14. Management of infantile hemangiomas-experience of a tertiary hospital.
Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
[TBL] [Abstract][Full Text] [Related]
15. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study.
Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X
Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973
[TBL] [Abstract][Full Text] [Related]
16. Retrospective case series of increased oral propranolol dosage for infantile hemangiomas.
Huang AH; Mannschreck D; Aggarwal P; Mahon M; Cohen BA
Pediatr Dermatol; 2020 Nov; 37(6):1057-1062. PubMed ID: 32869385
[TBL] [Abstract][Full Text] [Related]
17. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
18. Intralesional steroid in the era of propranolol for infantile hemangioma-Do we need it?
Pandey A; Srivastava A; Pant N; Singh S; Rawat J
J Plast Reconstr Aesthet Surg; 2023 Feb; 77():117-122. PubMed ID: 36566639
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study).
Chu DH; Castelo-Soccio L; Wan J; Gelfand JM; Shaddy RE; Shah KN; Perman MJ; Treat JR; Yan AC
Clin Pediatr (Phila); 2014 Oct; 53(11):1084-90. PubMed ID: 24849505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
